PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.

Keywords

Dopamine transporter, LRRK2, Dopaminergic, Vesicular monoamine transporter, Parkinsonism

References

• Positron emission tomography after MPTP: observations relating to the cause of Parkinson's diseaseOleksandr Astakhov, В. И. Петров, O. S. Fedynskii — 1985
• Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.M. C. de Rijk, L. J. Launer, Klaus Berger — 2000
• Recent Developments in Parkinson's DiseaseStanley Fahn, RL Elton, C. D. Marsden — 1986
• Familial Parkinson's disease: Clinical and genetic analysis of four Basque familiesCoro Paisán-Ruı́z, Amets Sáenz, Adolfo López de Munaín — 2005
• Criteria for diagnosing Parkinson's diseaseDonald B. Calne, B. J. Snow, C. Lee — 1992
• Synthesis and purification of ?-6-[18F]fluorodopaM.J. Adam, Salma Jivan — 1988
• A common LRRK2 mutation in idiopathic Parkinson's disease.William P. Gilks, Patrick M. Abou‐Sleiman, Sonia Gandhi — 2005
• PET studies of parkinsonism associated with mutation in the alpha-synuclein gene.Ali Samii, Katerina Markopoulou, Zbigniew K. Wszołek — 1999
• Prevalence of epilepsy in rural BoliviaEng‐King Tan, Joseph Jankovic — 1999
• In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's diseaseChong S. Lee, Ali Samii, Vesna Sossi — 2000
• Clinical and positron emission tomography of Parkinson's disease caused by LRRK2Dena Hernández, Coro Paisán-Ruı́z, Aideen McInerney‐Leo — 2005
• Western Nebraska Family (Family D) with Autosomal Dominant ParkinsonismZbigniew K. Wszołek, Beth Pfeiffer, Jimmy R. Fulgham — 1995
• Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations.Jennifer M. Kachergus, Ignácio F. Mata, Mary Hulihan — 2005
• Synthesis of the racemate and individual enantiomers of [11C]methylphenidate for studying presynaptic dopaminergic neuron with positron emission tomographyYu‐Shin Ding, Y Sugano, Joanna S. Fowler — 1994
• Differing patterns of striatal 18F‐dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyDavid J. Brooks, V. Ibanez, G. V. Sawle — 1990
• Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific.Michael R. Kilbourn, Lihsueh Lee, Thierry Vander Borght — 1995
• Genetic clues to the pathogenesis of Parkinson's diseaseMiquel Vila, Serge Przedborski — 2004
• Dopamine visualized in the basal ganglia of living manE.S. Garnett, G. Firnau, Claude Nahmias — 1983
• A proof of principle for targetry to produce ultra high quantities of 18F-fluoride.T.J. Ruth, K. Buckley, Kwon Soo Chun — 2001
• An 18O2 target for the production of [18F]F2Robert J. Nickles, M.E. Daube, T.J. Ruth — 1984

Cited by

• The importance of LRRK2 mutations in Parkinson disease.Anthony H.V. Schapira — 2006
• When does Parkinson's disease begin?Carles Gaig, Eduardo Tolosa — 2009
• Manganese Homeostasis and TransportJerome A. Roth, Sílvia Ponzoni, Michael Aschner — 2013
• The Nature of Progression in Parkinson’s Disease: An Application of Non-Linear, Multivariate, Longitudinal Random Effects ModellingJoão Ricardo Carvalho de Souza — 2013
• Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in miceA Masturzo — 2017
• In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia.Susanne Nikolaus, Christina Antke, Hans‐Wilhelm Müller — 2009
• Dopamine: PET Imaging and Parkinson Disease.Shichun Peng, Doris J. Doudet, Vijay Dhawan — 2013
• Hereditary early-onset Parkinsonism : the role of the FBXO7 proteinTianna Zhao — 2012
• Cerebral reorganization in premotor parkinsonismBart F.L. van Nuenen — 2012
• G2019S LRRK2 and aging confer susceptibility to proteasome inhibitor-induced neurotoxicity in nigrostriatal dopaminergic systemQian Xiao, Suosuo Yang, Weidong Le — 2015
• Altered motor phenotype and dopamine transmission associated with mutations of the parkinsonian gene LRRK2Francesco Longo, M. Morari, A. Cuneo — 2015
• Biomarkers for trials of neuroprotection in Parkinson's diseasePankaj Agarwal, A. Jon Stoessl — 2013
• Nuklearmedizinisches Imaging bei Parkinson-SyndromenJohannes Schwarz — 2010
• Weighted registration of 123I‐FP‐CIT SPECT images improves accuracy of binding potential estimates in pathologically low striatal uptakeAndrea Ciarmiello, Giampiero Giovacchini, Claudio Guidotti — 2013
• Optimizing diagnosis in Parkinson's disease: Radionuclide imaging.Julieta Arena, A. Jon Stoessl — 2016
• Clinical and pathologic features of families with LRRK2-associated Parkinson's disease.Nathaniel R. Whaley, Ryan J. Uitti, Dennis W. Dickson — 2006
• LRRK2 in Parkinson’s disease: genetic and clinical studies from patientsUdhaya Kumari, Eng‐King Tan — 2009
• Neurobildgebung genetischer Aspekte der Parkinson-KrankheitNorbert Brüggemann, J.P.M. van der Vegt, Christine Klein — 2010
• Positron emission tomography neuroimaging in Parkinson's disease.Clare Loane, Marios Politis — 2011
• Behavioral Deficits and Striatal DA Signaling in LRRK2 p.G2019S Transgenic Rats: A Multimodal Investigation Including PET NeuroimagingMatthew Walker, Mattia Volta, Stefano Cataldi — 2014

Related papers

• Comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism.Joanne Trinh, Rim Amouri, John E. Duda — 2014
• PARK8 LRRK2 parkinsonismKristoffer Haugarvoll, Zbigniew K. Wszołek — 2006
• Novel Pathogenic Lrrk2 p.Asn1437His substitution in familial Parkinson’s diseaseJan Aasly, Carles Vilariño‐Güell, Justus C. Dächsel — 2010
• PET Imaging of Dopamine Transporter(DAT) in the Diagnosis of Parkinson's DiseaseJiahe Tian — 2008
• Waiting on dopamine transporter imaging in drug induced parkinsonismJi Young Yun, C.Y. Lee, Beomseok Jeon — 2020
• [11C]RTI‐32 PET studies of the dopamine transporter in early dopa‐naive Parkinson's diseaseMark Guttman, JoAnn M. Burkholder, Stephen J. Kish — 1997
• Glucocerebrosidase mutations are not found in association with LRRK2 G2019S in subjects with parkinsonism.Michael J. Eblan, Sonja W. Scholz, Barbara Stubblefield — 2006
• Dopamine transporter levels in cocaine dependent subjects.Paul Crits‐Christoph, Andrew B. Newberg, Nancy Wintering — 2008
• Assessing brain dopamine system by dopamine transporter ligand ~(18)F-FP-CIT with positron emission tomographyWang Jian — 2004
• Striatal dopamine transporter binding in early to moderately advanced Parkinson's disease: monitoring of disease progression over 2 yearsMartina Choukèr, Klaus Tatsch, R. Linke — 2001